Stronghold Provides June 2024 Bitcoin Mining and Operational Update
July 05, 2024 17:00 ET
|
Stronghold Digital Mining, Inc.
NEW YORK, July 05, 2024 (GLOBE NEWSWIRE) -- Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold” or the “Company”) today provided the following updates regarding its operations and financial...
First Hawaiian to Report Second Quarter 2024 Financial Results on July 26, 2024
July 05, 2024 16:33 ET
|
First Hawaiian, Inc.
HONOLULU, Hawaii, July 05, 2024 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its second quarter 2024 financial results on Friday, July 26, 2024...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024 16:31 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases,...
Monthly information on share capital and company voting rights
July 05, 2024 16:30 ET
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, July 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders
July 05, 2024 16:30 ET
|
Cronos Group Inc.
TORONTO, July 05, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it will reconvene its 2024 Annual Meeting of Shareholders on...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
July 05, 2024 16:30 ET
|
Cellectis Inc.
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05 juill. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total...
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024 16:30 ET
|
Vera Therapeutics
BRISBANE, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 1, 2024, the Compensation Committee of Vera’s Board of Directors granted...
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to August 9, 2024
July 05, 2024 16:15 ET
|
Globalink Investment Inc.
New York, NY, July 05, 2024 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today...
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
July 05, 2024 16:15 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 05, 2024 (GLOBE NEWSWIRE) -- At the Extra General Meeting (the “EGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), the EGM adopted, inter alia, the...